Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 09:59 am Sale |
2024-02-14 | 13G | PDL BIOPHARMA INC PDLI |
DIMENSIONAL FUND ADVISORS INC | 7,392,656 6.500% |
-33,847 (-0.46%) |
Filing History |
| 2023-02-10 2:42 pm Sale |
2023-02-14 | 13G | PDL BIOPHARMA INC PDLI |
DIMENSIONAL FUND ADVISORS INC | 7,426,503 6.500% |
-32,390 (-0.43%) |
Filing History |
| 2022-02-08 3:52 pm Sale |
2022-02-14 | 13G | PDL BIOPHARMA INC PDLI |
DIMENSIONAL FUND ADVISORS INC | 7,458,893 6.500% |
-208,704 (-2.72%) |
Filing History |
| 2021-02-12 3:20 pm Sale |
2021-02-16 | 13G | PDL BIOPHARMA INC PDLI |
DIMENSIONAL FUND ADVISORS INC | 7,667,597 6.700% |
-1,863,352 (-19.55%) |
Filing History |
| 2021-02-11 4:22 pm Purchase |
2020-12-31 | 13G | PDL BIOPHARMA INC PDLI |
BRANDES INVESTMENT PARTNERS LLC | 7,046,701 6.170% |
1,235,621 (+21.26%) |
Filing History |
| 2021-02-10 7:32 pm Sale |
2020-12-31 | 13G | PDL BIOPHARMA INC PDLI |
Renaissance Technologies LLC | 0 0.000% |
-8,170,631 (Position Closed) |
Filing History |
| 2021-01-11 5:27 pm Purchase |
2020-12-30 | 13D | PDL BIOPHARMA INC PDLI |
Silver Point Capital, L.P. | 23,783,273 20.800% |
10,269,813 (+76.00%) |
Filing History |
| 2021-01-11 4:30 pm Purchase |
2020-12-30 | 13G | PDL BIOPHARMA INC PDLI |
Park West Asset Management LLC | 14,397,212 12.600% |
7,679,953 (+114.33%) |
Filing History |
| 2020-12-15 6:59 pm Purchase |
2020-12-10 | 13G | PDL BIOPHARMA INC PDLI |
Silver Point Capital, L.P. | 13,513,460 11.800% |
13,513,460 (New Position) |
Filing History |
| 2020-08-28 4:53 pm Purchase |
2020-08-19 | 13G | PDL BIOPHARMA INC PDLI |
Park West Asset Management LLC | 6,717,259 5.900% |
923,762 (+15.94%) |
Filing History |
| 2020-08-28 4:44 pm Purchase |
2020-08-18 | 13G | PDL BIOPHARMA INC PDLI |
Park West Asset Management LLC | 5,793,497 5.100% |
5,793,497 (New Position) |
Filing History |
| 2020-05-26 4:34 pm Sale |
2020-05-21 | 13D | Evofem Biosciences, Inc. EVFM |
PROTEIN DESIGN LABS INC PDLI |
1,778 6.300% |
-7,111 (-80.00%) |
Filing History |